Page last updated: 2024-09-04

naphthalenediimide and Prostatic Neoplasms, Castration-Resistant

naphthalenediimide has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Butovskaya, E; Cimino-Reale, G; Doria, F; Folini, M; Freccero, M; Nadai, M; Recagni, M; Richter, SN; Tassinari, M; Zaffaroni, N1

Other Studies

1 other study(ies) available for naphthalenediimide and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Down-Regulation of the Androgen Receptor by G-Quadruplex Ligands Sensitizes Castration-Resistant Prostate Cancer Cells to Enzalutamide.
    Journal of medicinal chemistry, 2018, 10-11, Volume: 61, Issue:19

    Topics: Androgen Receptor Antagonists; Benzamides; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; G-Quadruplexes; Gene Expression Regulation, Neoplastic; Humans; Imides; Ligands; Male; Naphthalenes; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Signal Transduction; Tumor Cells, Cultured

2018